ES8606390A1 - Un procedimiento para preparar nuevos peptidos atriales. - Google Patents

Un procedimiento para preparar nuevos peptidos atriales.

Info

Publication number
ES8606390A1
ES8606390A1 ES537520A ES537520A ES8606390A1 ES 8606390 A1 ES8606390 A1 ES 8606390A1 ES 537520 A ES537520 A ES 537520A ES 537520 A ES537520 A ES 537520A ES 8606390 A1 ES8606390 A1 ES 8606390A1
Authority
ES
Spain
Prior art keywords
ser
gly
arg
phe
atrial peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES537520A
Other languages
English (en)
Other versions
ES537520A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Washington
Washington University in St Louis WUSTL
Original Assignee
University of Washington
Washington University in St Louis WUSTL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Washington, Washington University in St Louis WUSTL filed Critical University of Washington
Publication of ES8606390A1 publication Critical patent/ES8606390A1/es
Publication of ES537520A0 publication Critical patent/ES537520A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE PEPTIDOS ATRIALES QUE TIENEN UNA ACTIVIDAD NATRIURETICA POTENTE Y QUE COMPRENDEN LA SECUENCIA DE AMINOACIDOS DE FORMULA GENERAL (1), Y SUS SALES, ESTERES O AMIDAS FISIOLOGICAMENTE ACEPTABLES. COMPRENDE LAS SIGUIENTES OPERACIONES: PRIMERA, SE PREPARA UN HOMOGENEIZADO BRUTO DE TEJIDO ATRIAL DE MAMIFERO Y SE HIERVE EL MATERIAL QUE SOBRENADA; SEGUNDA, SE DESALIFICA EL MATERIAL QUE SOBRENADA POR CROMATOGRAFIA DE FILTRACION EN GEL SOBRE RESINA DE DEXTRANO RETICULADO; TERCERA, SE CROMATOGRAFIA POR FILTRACION EN GEL LA FRACCION DE PROTEINAS SOBRE RESINA DE DEXTRANO RETICULADO; CUARTA, SE CROMATOGRAFIA POR CAMBIO DE IONES LA FRACCION DE PROTEINAS DE BAJO PESO MOLECULAR; QUINTA, SE CROMATOGRAFIA POR CROMATOGRAFIA DE LIQUIDOS DE ALTO RENDIMIENTO LAS DOS FRACCIONES PRINCIPALES DE PROTEINA; Y POR ULTIMO, SE RECUPERAN LAS FRACCIONES DE PEPTIDO ATRIAL SEPARADAS.
ES537520A 1983-11-10 1984-11-08 Un procedimiento para preparar nuevos peptidos atriales. Expired ES8606390A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55137283A 1983-11-10 1983-11-10
US06/569,684 US4496544A (en) 1983-11-10 1984-01-10 Atrial Peptides

Publications (2)

Publication Number Publication Date
ES8606390A1 true ES8606390A1 (es) 1986-04-01
ES537520A0 ES537520A0 (es) 1986-04-01

Family

ID=27069747

Family Applications (1)

Application Number Title Priority Date Filing Date
ES537520A Expired ES8606390A1 (es) 1983-11-10 1984-11-08 Un procedimiento para preparar nuevos peptidos atriales.

Country Status (12)

Country Link
US (1) US4496544A (es)
EP (1) EP0142487B1 (es)
JP (1) JPH0672156B2 (es)
AU (1) AU566235B2 (es)
DE (1) DE3480930D1 (es)
DK (1) DK533484A (es)
ES (1) ES8606390A1 (es)
FI (1) FI83661C (es)
GR (1) GR80905B (es)
IE (1) IE58819B1 (es)
IL (1) IL73466A (es)
NO (1) NO844489L (es)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0116784B1 (en) * 1982-02-22 1992-06-10 Queen's University At Kingston Atrial natriuretic factor
AU572173B2 (en) * 1983-08-29 1988-05-05 Institut De Recherches Cliniques De Montreal Natriuretic factors
JPS60136596A (ja) * 1983-12-26 1985-07-20 Suntory Ltd ペプチド及びこれを有効成分とする利尿剤
US4952561A (en) * 1984-02-07 1990-08-28 Merck & Co., Inc. Cardiac atrial peptides
JPH0794473B2 (ja) * 1984-03-02 1995-10-11 サントリー株式会社 新規なペプチド及びこれを有効成分とする利尿剤
EP0180615B1 (en) * 1984-04-19 1995-04-05 Scios Nova Inc. Novel atrial natriuretic/vasodilator polypeptides
US5212286A (en) * 1984-04-19 1993-05-18 Scios Nova Inc. Atrial natriuretic/vasodilator peptide compounds
US4618600A (en) * 1984-04-19 1986-10-21 Biotechnology Research Associates, J.V. Novel polypeptide diuretic/vasodilators
WO1985004872A1 (en) * 1984-04-24 1985-11-07 The Salk Institute For Biological Studies Atrial peptide analogs
JPH0672157B2 (ja) * 1984-08-29 1994-09-14 味の素株式会社 新規ペプチド
US4652549A (en) * 1985-01-22 1987-03-24 Merck & Co., Inc. Cardiac anti-hypertrophic agents
US5087564A (en) * 1985-06-20 1992-02-11 Monsanto Company Release of recombinant peptides from polypeptides using V8 endopeptidase
US4757048A (en) * 1985-11-05 1988-07-12 Biotechnology Research Associates J.V. Synthetic analogs of atrial natriuretic peptides
JP3042782B2 (ja) * 1985-11-05 2000-05-22 サイオス インコーポレイテッド 心房性ナトリウム尿***亢進ペプチド類似化合物
KR940001711B1 (ko) * 1985-11-05 1994-03-05 캘리포니아 바이오테크널러지 인코포레이티드 심방성 나트륨이뇨성 펩티드의 동족체
DE3614833A1 (de) * 1986-01-16 1987-07-23 Hoechst Ag Peptide mit vasorelaxierender, natriuretischer und diuretischer wirkung, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung
US4716147A (en) * 1986-03-27 1987-12-29 Monsanto Company Synthetic airial peptides
US4721704A (en) * 1986-05-09 1988-01-26 Peninsula Laboratories, Inc. Potent synthetic atrial peptide analogs
EP0246795A3 (en) * 1986-05-20 1990-04-04 Advanced Peptide Development Limited Synthetic natriuretic peptides
US4740499A (en) * 1986-07-28 1988-04-26 Monsanto Company Method of enhancing the bioactivity of atrial peptides
US5565606A (en) * 1986-10-21 1996-10-15 Hoechst Aktiengesellschaft Synthesis of peptide aminoalkylamides and peptide hydrazides by the solid-phase method
DE3723551A1 (de) * 1987-07-16 1989-01-26 Hoechst Ag Peptide mit vasorelaxierender, natriuretischer und diuretischer wirkung, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung
US4804650A (en) * 1986-10-28 1989-02-14 Biotechnology Research Associates, J.V. Analogs of atrial natriuretic peptides
US5500230A (en) * 1987-01-23 1996-03-19 The General Hospital Corporation Method for treatment of glaucoma with nitrogen containing guanylate cyclase activators
WO1988005306A1 (en) * 1987-01-23 1988-07-28 The General Hospital Corporation Atriopeptins, guanylate cyclase activators, and phosphodiesterase inhibitors as treatment for glaucoma, hydrocephalus and cerebral edema (cranial fluid volume dysfunction)
IT1216865B (it) 1987-02-03 1990-03-14 Eniricerche Spa Derivato argininico, procedimento per la sua preparazione e suo impiego nelle sintesi peptidiche.
ATE90108T1 (de) * 1987-10-09 1993-06-15 Takeda Chemical Industries Ltd Vasokonstriktor-peptid.
US4935492A (en) * 1987-12-24 1990-06-19 California Biotechnology Inc. Cyclic analogs of atrial natriuretic peptides
US5047397A (en) * 1988-08-26 1991-09-10 California Biotechnology Inc. Linear analogs of atrial natriuretic peptides
CA1339210C (en) 1988-05-31 1997-08-05 John Lewicki Recombinant techniques for production of novel natriuretic and vasodilator peptides
US5114923A (en) * 1988-05-31 1992-05-19 California Biotechnology Inc. Recombinant techniques for production of novel natriuretic and vasodilator peptides
JP2801079B2 (ja) * 1990-11-14 1998-09-21 サントリー株式会社 Ａｎｐ関連新規ペプチド
JP2809533B2 (ja) * 1991-01-31 1998-10-08 壽之 松尾 Ｃｎｐ類似体ペプチド
US5846932A (en) * 1993-11-12 1998-12-08 Genentech, Inc. Receptor specific atrial natriuretic peptides
US6525022B1 (en) 1993-11-12 2003-02-25 Genentech, Inc. Receptor specific atrial natriuretic peptides
US5665704A (en) * 1993-11-12 1997-09-09 Genentech, Inc. Receptor specific atrial natriuretic peptides
US5486519A (en) * 1994-08-22 1996-01-23 Greenwald; James E. Method for treatment of acute renal failure
US5521191A (en) * 1994-10-17 1996-05-28 Washington University Method for treatment of arterial stenosis
US20060177870A1 (en) * 2003-04-28 2006-08-10 Ciphergen Biosystems, Inc Immunoassays
CN101208353B (zh) * 2003-06-20 2011-12-14 梅约医学教育与研究基金会 脑利尿钠肽的同种型
KR101434612B1 (ko) * 2006-03-30 2014-08-26 팔라틴 테크놀로지스 인코포레이티드 사이클릭 나트륨 이뇨 펩타이드 구조물
AU2007233123A1 (en) * 2006-03-30 2007-10-11 Palatin Technologies, Inc. Linear natriuretic peptide constructs
US8580746B2 (en) 2006-03-30 2013-11-12 Palatin Technologies, Inc. Amide linkage cyclic natriuretic peptide constructs
CN101501067B (zh) 2006-08-08 2013-01-16 梅约医学教育与研究基金会 利尿和利尿钠的多肽
WO2009036448A2 (en) * 2007-09-15 2009-03-19 Mayo Foundation For Medical Education And Research Natriuretic peptide receptor-c agonists
JP2014525439A (ja) 2011-08-30 2014-09-29 メイヨ・ファウンデーション・フォー・メディカル・エデュケーション・アンド・リサーチ ナトリウム利尿ポリペプチド
WO2013103896A1 (en) 2012-01-06 2013-07-11 Mayo Foundation For Medical Education And Research Treating cardiovascular or renal diseases

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA846084B (en) * 1983-08-29 1985-05-29 Montreal Inst Rech Cliniques Natriuretic factors

Also Published As

Publication number Publication date
FI844424A0 (fi) 1984-11-09
AU566235B2 (en) 1987-10-15
DK533484D0 (da) 1984-11-09
NO844489L (no) 1985-05-13
EP0142487B1 (en) 1990-01-03
DE3480930D1 (de) 1990-02-08
US4496544A (en) 1985-01-29
IE842881L (en) 1985-05-10
FI83661C (fi) 1991-08-12
FI844424L (fi) 1985-05-11
GR80905B (en) 1985-04-02
ES537520A0 (es) 1986-04-01
DK533484A (da) 1985-05-11
IL73466A0 (en) 1985-02-28
JPS60214797A (ja) 1985-10-28
IE58819B1 (en) 1993-11-17
JPH0672156B2 (ja) 1994-09-14
FI83661B (fi) 1991-04-30
IL73466A (en) 1989-03-31
AU3525284A (en) 1985-05-16
EP0142487A3 (en) 1986-04-30
EP0142487A2 (en) 1985-05-22

Similar Documents

Publication Publication Date Title
ES8606390A1 (es) Un procedimiento para preparar nuevos peptidos atriales.
EP0138854A4 (en) ANTIGENICALLY ACTIVE AMINO ACID SEQUENCES.
OA07983A (en) A novel human physiologically active polypeptide.
JPS6419053A (en) Novel peptide derivative, manufacture and use
EP0182372A3 (en) New factor viii coagulant polypeptides
IL74426A (en) Atrial peptides and pharmaceutical compositions comprising them
KR0180256B1 (en) Bpc peptides, their preparation and use
DE3472793D1 (en) A novel physiologically active polypeptide
DE3782073D1 (en) Synthetische atriale peptide.
CS8708732A2 (en) Method of hv1, hv2, hv3 hirodin forms' one variant production
GB2151233B (en) 2,5-diketo-d-gluconic acid reductase
PH23237A (en) Novel 16, 17-acetalsubstituted pregnane 21-oic acid derivaives
GB8528122D0 (en) Amino & imino acid & esters
IL80300A0 (en) Mitogenic peptides
GB2013210A (en) Therapeutically Useful Pseudopeptides, Compositions Containing the Same and Methods of Preparation and Use
CS544987A1 (en) 2,4-dioxy-4-(4-pentyloxyphenyl) butanoic acid's esters
IE871349L (en) Crystalline amino-protected amino acids.
IE883736L (en) Amino acid derivatives - sweetening agents
IE881809L (en) Amino acid 1, 2- diketo derivatives
ZA848787B (en) Novel atrial peptides

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20001102